Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 20;16(8):e67287.
doi: 10.7759/cureus.67287. eCollection 2024 Aug.

Empowering Women's Health: Examining the Impact of Human Papillomavirus (HPV) Vaccination on Cervical Cancer Treatment and Beyond

Mohan Babu  1 , Anjali Thakur  2 , Mukthavaram Sravyasri  3 , Gagan Gunjan  4 , Suneeth Shetty  5 , Kinnor Das  6 , Ishan Y Pandya  7 , Lavanya  8
Affiliations
Review

Empowering Women's Health: Examining the Impact of Human Papillomavirus (HPV) Vaccination on Cervical Cancer Treatment and Beyond

Mohan Babu et al. Cureus. .

Abstract

This study aims to identify the change in the health status of women, particularly in cervical cancer treatment through HPV vaccination. Thus, the research aims to measure the reduction in the incidence of cervical cancer in vaccinated women and evaluate the impact of HPV vaccination on the overall health and well-being of women treated for cervical cancer. The paper uses a research approach that involves reviewing the literature, analysing epidemiological data, and assessing the impact of the vaccination program. Major observations suggest that many developed countries' campaigns have reduced cervical cancer and enhanced treatment. Further, the study also addresses some additional effects of the intervention, both health-related with an emphasis on the decrease in healthcare costs and an enhancement of the quality of life among women, and social with a focus on the changes in women's status as a result of vaccination. The research also focusses on the community and economic points of view on HPV vaccination programs, its problems and opportunities regarding socio-economic factors, cultural disparities, and healthcare systems. This study implies that working on those barriers by implementing effective interventions, increasing awareness, and demanding relevant changes in policies could improve vaccination levels as well as outcomes. Hence, this research supports HPV vaccination as vital to the future health status of women. Through the use of survey data and the adoption of a public health perspective, the study can fill existing gaps in the literature on preventive interventions and cervical malignancies and consequently contribute to the enhancement of women's health, particularly in developing countries.

Keywords: cervical cancer; cervical cancer screening; immunization programs; preventive healthcare; public health; societal impact; women's health.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Socio-economic factors influencing human papillomavirus (HPV) vaccination success
This image has been created by the author.
Figure 2
Figure 2. Factors affecting human papillomavirus (HPV) vaccination programs
This image has been created by the author.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Cervical screening rates for women vaccinated against human papillomavirus. Budd AC, Brotherton JM, Gertig DM, Chau T, Drennan KT, Saville M. Med J Aust. 2014;201:279–282. - PubMed
    1. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Bruni Bruni, Diaz M, Barrionuevo-Rosas L, et al. Lancet. 2016;4:453–463. - PubMed
    1. Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months. Lazcano-Ponce E, Stanley M, Muñoz N, et al. Vaccine. 2014;32:725–732. - PubMed
    1. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM. BMC Med. 2013;11:227. - PMC - PubMed
    1. Human papillomavirus vaccine decision-making in Da Nang, Vietnam: perceived spousal and adolescent-parent concordance. Breitkopf CR, Pearson HC, Dinh TA, et al. https://doi.org/10.1016/j.vaccine.2009.02.021. Vaccine. 2009;27:2367–2371. - PubMed

LinkOut - more resources